Resolute Onyx Polymer-Based Stent Continues to See Similar Safety and Efficacy as Polymer-Free BioFreedom Stent at 2 Years: Onyx ONE
The Resolute Onyx polymer-based zotarolimus-eluting stent (ZES) had similar safety and effectiveness outcomes compared to the BioFreedom polymer-free biolimus A9-coated stent in high-bleeding-risk coronary artery disease (CAD) patients undergoing percutaneous coronary intervention (PCI) in the final 2-year follow-up of the randomized Onyx ONE trial.